Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancer.
Publication year
2012Source
Annals of Oncology, 23, 3, (2012), pp. 801-2ISSN
Annotation
01 maart 2012
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Oncology
Clinical Pharmacy
Journal title
Annals of Oncology
Volume
vol. 23
Issue
iss. 3
Page start
p. 801
Page end
p. 2
Subject
N4i 3: Poverty-related infectious diseases NCEBP 13: Infectious diseases and international health; NCMLS 2: Immune Regulation ONCOL 3: Translational researchThis item appears in the following Collection(s)
- Academic publications [227693]
- Faculty of Medical Sciences [86198]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.